AI assistant
Sending…
DAVITA INC. — Director's Dealing 2015
Aug 10, 2015
30643_dirs_2015-08-10_2a44843e-a812-4e42-858b-4b329615ba83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2015-08-06
Reporting Person: BERG CHARLES (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-06 | Common Stock | M | 24000 | $41.465 | Acquired | 47030 | Direct |
| 2015-08-06 | Common Stock | F | 12364 | $80.49 | Disposed | 34666 | Direct |
| 2015-08-06 | Common Stock | S | 11636 | $81.0058 | Disposed | 23030 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-06 | Stock Appreciation Rights | $41.465 | M | 24000 | Disposed | 2016-06-06 | Common Stock (24000) | Direct |
Footnotes
F1: Represents the weighted average sale price of $81.0058. The range of prices for the sale of these shares was $80.90 - $81.17, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: The Stock Appreciation Rights were granted on 6/6/2011 and vested 100% on 6/6/2012.
More from DAVITA INC.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5